IL-33 Polyclonal Antibody

Interleukin-33 encoded by IL33 is a cytokine that binds to the IL1RL1/ST2 receptor. The encoded protein is involved in the maturation of Th2 cells and the activation of mast cells, basophils, eosinophils and natural killer cells. Several transcript variants encoding different isoforms have been found for this gene.

The IL-33 Polyclonal Antibody is a highly specific and sensitive tool designed for the detection and quantification of interleukin-33 (IL-33) in various biological samples. IL-33 is a pro-inflammatory cytokine that plays a crucial role in immune responses and is implicated in various diseases, including asthma, rheumatoid arthritis, and inflammatory bowel disease.

This polyclonal antibody has been meticulously developed and rigorously validated to ensure optimal performance and reliability. It exhibits exceptional specificity, binding exclusively to IL-33 without cross-reactivity to other related cytokines. The antibody's high sensitivity enables accurate and precise measurements, even in samples with low IL-33 concentrations.

The IL-33 Polyclonal Antibody is suitable for a wide range of applications, including enzyme-linked immunosorbent assays (ELISA), Western blotting, immunohistochemistry, and flow cytometry. Its versatility allows for the detection and analysis of IL-33 in various sample types, such as serum, plasma, cell lysates, and tissue sections.

This antibody is produced using state-of-the-art techniques, ensuring batch-to-batch consistency and reproducibility. It is supplied as a purified and lyophilized form, providing long-term stability and ease of storage. The reconstitution process is straightforward, allowing for quick and convenient usage.

With its exceptional specificity, sensitivity, and versatility, the IL-33 Polyclonal Antibody is an indispensable tool for researchers and clinicians studying the role of IL-33 in immune responses and disease pathogenesis. Its reliable performance and ease of use make it an ideal choice for a wide range of applications in both basic research and clinical settings.